Desferrioxamine shows different potentials for enhancing 5-aminolaevulinic acid-based photodynamic therapy in several cutaneous cell lines

Lasers in Medical Science

Volumn 25, Issue 2, 2010, Pages 251-257

  Yang, Jiabin ^a   Xia, Yumin ^b   Liu, Xiaoming ^b   Jiang, Shan ^b   Xiong, Layuan ^b  

^a YANGTZE UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Aminolaevulinic acid; Desferrioxamine; Fibroblasts; Keratinocytes; Photodynamic therapy; Protoporphyrin IX; Squamous cell carcinoma

Indexed keywords

AMINOLEVULINIC ACID; DEFEROXAMINE MESYLATE; PROTOPORPHYRIN; DEFEROXAMINE; IRON CHELATING AGENT; PHOTOSENSITIZING AGENT;

ARTICLE; CELL DEATH; CELL STRAIN HEPG2; CELL STRUCTURE; CLINICAL EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG EFFICACY; FIBROBLAST; HUMAN; HUMAN CELL; NECROSIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN CELL; CELL LINE; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; METHODOLOGY; PATHOLOGY; PHOTOCHEMOTHERAPY; SKIN DISEASE;

AMINOLEVULINIC ACID; CELL DEATH; CELL LINE; DEFEROXAMINE; DRUG SYNERGISM; FIBROBLASTS; HUMANS; IRON CHELATING AGENTS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN DISEASES;

EID: 77949765682     PISSN: 02688921     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10103-009-0721-0     Document Type: Article

References (33)

1. Krammer B, Plaetzer K (2008) ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 7:283-289
2. Akilov OE, Kosaka S, O'Riordan K, Hasan T (2007) Parasiticidal effect of delta-amino- levulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells. Exp Dermatol 16:651-660
3. Morton CA, McKenna KE, Rhodes LE, British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group (2008) Guidelines for topical photodynamic therapy: update. Br J Dermatol 159:1245-1266
4. Fien SM, Oseroff AR (2007) Photodynamic therapy for nonmelanoma skin cancer. J Natl Compr Cancer Netw 5:531-540
5. Gerritsen MJ, Smits T, Kleinpenning MM, van de Kerkhof PC, van Erp PE (2009) Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology 218:193-202
6. Smucler R, Vlk M (2008) Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma. Lasers Surg Med 40:153-158
7. van den Akker JT, Boot K, Vernon DI, Brown SB, Groenendijk L, van Rhoon GC, Sterenborg HJ (2004) Effect of elevating the skin temperature during topical ALA application on in vitro ALA penetration through mouse skin and in vivo PpIX production in human skin. Photochem Photobiol Sci 3:263-267
8. Ahmadi S, McCarron PA, Donnelly RF, Woolfson AD, McKenna K (2004) Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study. Exp Dermatol 13:445-451
9. de Haas ER, Kruijt B, Sterenborg HJ, Martino Neumann HA, Robinson DJ (2006) Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. J Invest Dermatol 126:2679-2686
10. Fukuda H, Casas A, Batlle A (2005) Aminolevulinic acid: from its unique biological function to its star role in photodynamic therapy. Int J Biochem Cell Biol 37:272-276
11. Curnow A, Pye A (2007) Biochemical manipulation via iron chelation to enhance porphyrin production from porphyrin precursors. J Environ Pathol Toxicol Oncol 26:89-103
12. Juzeniene A, Juzenas P, Iani V, Moan J (2007) Topical applications of iron chelators in photosensitization. Photochem Photobiol Sci 6:1268-1274
13. Liu HF, Xu SZ, Zhang CR (2004) Influence of CaNa2 EDTA on topical 5-aminolaevulinic acid photodynamic therapy. Chin Med J 117:922-926
14. Pye A, Curnow A (2007) Direct comparison of deltaaminolevulinic acid and methyl-aminolevulinate-derived protoporphyrin IX accumulations potentiated by desferrioxamine or the novel hydroxypyridinone iron chelator CP94 in cultured human cells. Photochem Photobiol 83:766-773
15. Cable H, Lloyd JB (1999) Cellular uptake and release of two contrasting iron chelators. J Pharm Pharmacol 51:131-134
16. Alvarez MG, Lacelli MS, Rivarola V, Batlle A, Fukuda H (2007) 5-Aminolevulinic acid-mediated photodynamic therapy on Hep-2 and MCF-7c3 cells. J Environ Pathol Toxicol Oncol 26:75-82
17. Sterin-Borda L, Furlan C, Orman B, Borda E (2007) Differential regulation on human skin fibroblast by alpha1 adrenergic receptor subtypes. Biochem Pharmacol 74:1401-1412
18. Ayala F, Grimaldi E, Perfetto B, Donnarumma M, De Filippis A, Donnarumma G, Tufano MA (2008) 5-Aminolaevulinic acid and photodynamic therapy reduce HSV-1 replication in HaCat cells through an apoptosis-independent mechanism. Photodermatol Photoimmunol Photomed 24:237-243
19. Konac E, Ekmekci A, Yurtcu E, Ergun MA (2005) An in vitro study of cytotoxic effects of gossypol on human epidermoid larynx carcinoma cell line (HEp-2). Exp Oncol 27:81-83
20. Lee JB, Choi JY, Chun JS, Yun SJ, Lee SC, Oh J, Park HR (2008) Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin. Br J Dermatol 159:61-67
21. Gilmore BF, McCarron PA, Morrow DI, Murphy DJ,Woolfson AD, Donnelly RF (2006) In vitro phototoxicity of 5-aminolevulinic acid and its methyl ester and the influence of barrier properties on their release from a bioadhesive patch. Eur J Pharm Biopharm 63: 295-309
22. Lu S, Chen JY, Zhang Y, Ma J, Wang PN, Peng Q (2008) Fluorescence detection of protoporphyrin IX in living cells: a comparative study on single- and two-photon excitation. J Biomed Opt 13:024014
23. Saczko J, Kulbacka J, Chwilkowska A, Drag-Zalesiniska M, Wysocka T, Lugowski M, Banas T (2005) The influence of photodynamic therapy on apoptosis in human melanoma cell line. Folia Histochem Cytobiol 43:129-132
24. Chen S, Cheng AC, Wang MS, Peng X (2008) Detection of apoptosis induced by new type gosling viral enteritis virus in vitro through fluorescein annexin V-FITC/PI double labeling. World J Gastroenterol 14:2174-2178
25. Tsai JC, Wu CL, Chien HF, Chen CT (2005) Reorganization of cytoskeleton induced by 5-aminolevulinic acid-mediated photodynamic therapy and its correlation with mitochondrial dysfunction. Lasers Surg Med 36:398-408
26. Kuzelová K, Grebenová D, Pluskalová M, Marinov I, Hrkal Z (2004) Early apoptotic features of K562 cell death induced by 5-aminolaevulinic acid-based photodynamic therapy. J Photochem Photobiol B 73:67-78
27. Tsai T, Hong RL, Tsai JC, Lou PJ, Ling IF, Chen CT (2004) Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells. Lasers Surg Med 34:62-72
28. Kicic A, Chua AC, Baker E (2001) Effect of iron chelators on proliferation and iron uptake in hepatoma cells. Cancer 92:3093-3110
29. Hodges YK, Reese SM, Pahl PM, Horwitz LD (2005) Paradoxical effects of iron chelation on growth of vascular endothelial cells. J Cardiovasc Pharmacol 45:539-544
30. Jin H, Terai S, Sakaida I (2007) The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosis. J Gastroenterol 42:475-484
31. Ziolkowski P, Osiecka BJ, Siewinski M, Bronowicz A, Ziolkowska J, Gerber-Leszczyszyn H (2006) Pretreatment of plantar warts with azone enhances the effect of 5-aminolevulinic acid photodynamic therapy. J Environ Pathol Toxicol Oncol 25:403-409
32. Pierre MB, Ricci E Jr, Tedesco AC, Bentley MV (2006) Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy. Pharm Res 23:360-366
33. Boddé HE, Roemelé PE, Star WM (2002) Quantification of topically delivered 5-aminolevulinic acid by iontophoresis across ex vivo human stratum corneum. Photochem Photobiol 75:418-423